25700349	2	5	ENSP00000417404	DOID:2352	We previously discovered that the MYDISEASETOKEN protein MYGENETOKEN, a negative regulator of iron absorption, dampens classical MHC I antigen presentation.
24055163	1	1	ENSP00000223051	DOID:2352	MYGENETOKEN-related hereditary MYDISEASETOKEN as a frequent cause of primary iron overload in patients from Central-Southern Italy.
28110135	1	1	ENSP00000261024	DOID:2352	Identification of hereditary MYDISEASETOKEN pedigrees and a novel MYGENETOKEN mutation in Chinese population.
21054916	2	10	ENSP00000222304	DOID:2352	Recent advances in our understanding of MYGENETOKEN and body iron homeostasis provide the potential for a range of new diagnostic and therapeutic tools for MYDISEASETOKEN and related conditions.
23651749	2	2	ENSP00000417404	DOID:2352	In Caucasians, mutations in the MYGENETOKEN-gene account for the most common form of MYDISEASETOKEN (type 1).
22897067	2	11	ENSP00000222304	DOID:2352	In the setting of MYDISEASETOKEN, it has been suggested that MYGENETOKEN could be useful to stratify molecular testing, or to optimize the frequency of phlebotomies, but this remains to be investigated.
10772870	2	4	ENSP00000417404	DOID:2352	To date, there are no published data on the cellular location and regulation of MYGENETOKEN in patients with MYDISEASETOKEN who are homozygous for C282Y.
16545687	1	1	ENSP00000417404	DOID:2352	Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with MYGENETOKEN-related MYDISEASETOKEN: a case-control study.
9620340	2	2	ENSP00000417404	DOID:2352	Recently, PCT has also been associated with mutations in the MYGENETOKEN gene that are associated with HLA-linked hereditary MYDISEASETOKEN.
26418842	1	1	ENSP00000355607	DOID:2352	Further support for the association of MYGENETOKEN variant rs11558492 with severe iron overload in MYDISEASETOKEN.
24653703	1	1	ENSP00000417404	DOID:2352	Molecular basis of MYGENETOKEN-MYDISEASETOKEN.
14618419	2	2	ENSP00000417404	DOID:2352	C282Y and H63D mutations in the MYDISEASETOKEN (MYGENETOKEN) gene are associated with increased serum iron levels and consequently with hereditary MYDISEASETOKEN.
11313312	1	1	ENSP00000417404	DOID:2352	Intestinal iron uptake determined by divalent metal transporter is enhanced in MYGENETOKEN-deficient mice with MYDISEASETOKEN.
25776452	2	1	ENSP00000417404	DOID:2352	The treatment of MYGENETOKEN-related MYDISEASETOKEN, one of the most common genetic diseases, is based on phlebotomies whose tolerance is evaluated by regular monitoring of hemoglobin.
23678850	2	6	ENSP00000417404	DOID:2352	The association between haemosiderin counts and degenerative and vascular brain pathology, clinical data, and the MYDISEASETOKEN (MYGENETOKEN) gene H63D genotype were analysed.
12673276	2	14	ENSP00000417404	DOID:2352	Our study shows that the MYGENETOKEN C282Y and H63D are determinants of iron parameters in the elderly and will be effective in detecting individuals at high risk of MYDISEASETOKEN.
12508966	1	1	ENSP00000417404	DOID:2352	Clinical relevance of MYDISEASETOKEN-related MYGENETOKEN C282Y/H63D gene mutations in patients on chronic dialysis.
18752323	2	2	ENSP00000417404	DOID:2352	"This article provides an update of recent developments and key issues relating to iron homeostasis and inherited disorders of iron overload, with emphasis on MYGENETOKEN-related HH, and is based on the content of the American Association for the Study of Liver Diseases Single-Topic Conference entitled ""MYDISEASETOKEN: What has Happened After MYGENETOKEN?"" which was held at the Emory Convention Center in Atlanta, September 7-9, 2007."
11078891	2	2	ENSP00000417404	DOID:2352	In this report we demonstrate that the predominant hereditary MYDISEASETOKEN mutation, C282Y(2) MYGENETOKEN, does not reduce ferritin expression.
9385688	1	1	ENSP00000417404	DOID:2352	Genetic MYDISEASETOKEN: why is discovery of the MYGENETOKEN gene of interest to rheumatologists?
25654085	2	4	ENSP00000417404	DOID:2352	Two groups were characterized: C282Y/C282Y or C282Y/H63D genotypes (n = 16) were the MYGENETOKEN hereditary MYDISEASETOKEN (MYGENETOKEN-HH) group; and C282Y and H63D single heterozygotes, the H63D/H63D genotype, and wild-type were considered group 2 (n = 92).
15990686	2	2	ENSP00000417404	DOID:2352	The C282Y and H63D mutations in the MYDISEASETOKEN (MYGENETOKEN) gene are associated with increased serum iron levels and net iron accumulation.
91216	2	1	ENSP00000366005	DOID:2352	MYGENETOKEN and B antigens were defined in 154 unrelated idiopathic MYDISEASETOKEN patients.
22796612	1	1	ENSP00000417404	DOID:2352	[Hereditary MYDISEASETOKEN MYGENETOKEN: regulatory and economic aspects of diagnosis and medical management].
19700664	2	1	ENSP00000417404	DOID:2352	Mutations of MYGENETOKEN are associated with hereditary MYDISEASETOKEN, but their influence on host susceptibility to infection is incompletely understood.
15951546	2	8	ENSP00000223051	DOID:2352	Homozygous MYGENETOKEN-KO mice had no MYGENETOKEN protein expression and developed significant iron overload typical of MYGENETOKEN associated MYDISEASETOKEN.
15671444	2	3	ENSP00000417404	DOID:2352	The aim of the present study was to quantify LPI in MYGENETOKEN genetic MYDISEASETOKEN (GH) and to characterize the mechanisms accounting for its appearance.
18624620	2	1	ENSP00000417404	DOID:2352	Genetic predisposition to MYDISEASETOKEN involves several different point mutations in the MYGENETOKEN gene.
10073265	2	2	ENSP00000417404	DOID:2352	The MYDISEASETOKEN gene (MYGENETOKEN) was identified by positional cloning in 1996.
17689879	2	3	ENSP00000417404	DOID:2352	I propose that hereditary MYDISEASETOKEN and in particular the common MYGENETOKEN C282Y mutation may represent an adaptation to decreased dietary iron in cereal grain-based Neolithic diets.
19008010	2	3	ENSP00000417404	DOID:2352	Data on MYGENETOKEN-genotype, iron parameters, demographics, lifestyle factors and health, were collected from 224 Dutch C282Y homozygous patients with clinically diagnosed HH and 735 of their first-degree family members (FDFM), all participating in the MYDISEASETOKEN FAmily Study (HEFAS).
10660483	2	1	ENSP00000417404	DOID:2352	Two amino acid variants in the MYGENETOKEN gene, C282Y and H63D, have been reported in most cases of hereditary MYDISEASETOKEN.
16533407	2	2	ENSP00000417404	DOID:2352	Twenty-eight percent of 80 Alabama white MYDISEASETOKEN probands with MYGENETOKEN C282Y homozygosity previously reported having Native American ancestry, but the possible effect of this ancestry on MYDISEASETOKEN phenotypes was unknown.
23582421	2	11	ENSP00000362207	DOID:2352	MYGENETOKEN:HHCL rats are the first genetic rat model of hereditary MYDISEASETOKEN and may prove useful for understanding the molecular mechanisms underlying the regulation of iron metabolism.
15993396	1	1	ENSP00000417404	DOID:2352	Beware of multiple comparisons: a study of symptoms associated with mutations of the MYGENETOKEN MYDISEASETOKEN gene.
18363869	2	1	ENSP00000417404	DOID:2352	The MYDISEASETOKEN mutation, C282Y of the MYGENETOKEN gene, seems to have originated from a single event which once occurred in a person living in the north west of Europe carrying human leukocyte antigen (HLA)-A3-B7.
11313241	2	1	ENSP00000417404	DOID:2352	Hereditary MYDISEASETOKEN usually results from C282Y homozygosity in the MYGENETOKEN gene on chromosome 6p.
16081371	2	6	ENSP00000222304	DOID:2352	Patients carrying mutations in these molecules or in MYGENETOKEN itself develop systemic iron loading (or MYDISEASETOKEN) due to their inability to down regulate iron absorption.
23049448	2	2	ENSP00000417404	DOID:2352	However, since 1996, it is known that MYGENETOKEN mutations explain about 80% of HH cases, with the remaining around 20% denominated non-MYGENETOKEN MYDISEASETOKEN.
12809944	2	5	ENSP00000223051	DOID:2352	Therefore, we investigated the MYGENETOKEN gene of 6 sporadic and 5 familiar cases of Japanese MYDISEASETOKEN.
12737949	1	1	ENSP00000417404	DOID:2352	MYDISEASETOKEN gene (MYGENETOKEN) mutations in South East Asia: a potential for iron overload.
17098454	1	1	ENSP00000417404	DOID:2352	Hepatic iron metabolism gene expression profiles in MYGENETOKEN associated hereditary MYDISEASETOKEN.
17597476	1	1	ENSP00000417404	DOID:2352	Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white MYGENETOKEN C282Y homozygotes in the MYDISEASETOKEN and iron overload screening study.
12547214	2	1	ENSP00000417404	DOID:2352	MYGENETOKEN-associated hereditary MYDISEASETOKEN is characterized by imbalances of iron homeostasis and alterations in intestinal iron absorption.
15925529	1	1	ENSP00000417404	DOID:2352	[MYGENETOKEN MYDISEASETOKEN: pathogenic and diagnostic approach].
12714262	2	1	ENSP00000417404	DOID:2352	Mutations in the class I-like Major Histocompatibility Complex gene MYGENETOKEN are associated with hereditary MYDISEASETOKEN (HH), a disorder caused by excessive iron uptake.
23953397	2	1	ENSP00000417404	DOID:2352	Most adults affected with hereditary MYDISEASETOKEN are homozygous for a single point mutation of MYGENETOKEN (p.Cys282Tyr).
16368718	2	4	ENSP00000417404	DOID:2352	Measured by a recently developed high-throughput fluorescence-based assay, serum NTBI was found to be higher in both homozygotes of MYGENETOKEN C282Y mutation of hereditary MYDISEASETOKEN (7.9+/-0.6 microM, n=9, P&lt;0.001) and heterozygotes (4.0+/-0.5 microM, n=8, P&lt;0.001), compared with controls (1.6+/-0.2 microM, n=21).
9373599	2	2	ENSP00000417404	DOID:2352	A candidate gene for hereditary MYDISEASETOKEN has recently been reported (MYGENETOKEN) and a specific missense mutation (Cys282Tyr) has been identified in 85% of patients with the disorder.
24319245	2	1	ENSP00000417404	DOID:2352	Hereditary MYDISEASETOKEN (HH) due to homozygosity for the C282Y mutation in the MYGENETOKEN gene is a common inherited iron overload disorder in whites of northern European descent.
10424282	2	7	ENSP00000219070	DOID:2352	Serum type IV collagen concentration was significantly increased in MYDISEASETOKEN patients compared to controls (130+/-79 ng/ml vs 81 +/- 17 ng/ml, p&lt;0.05) and was significantly correlated with both the grade of histological fibrosis (r=0.67, p&lt;0.0001) and serum MYGENETOKEN levels (r=0.42, p&lt;0.05).
17053738	2	11	ENSP00000417404	DOID:2352	The absence of C282Y mutation (MYGENETOKEN gene) ruled out a diagnosis of genetic MYDISEASETOKEN.
9021970	1	1	ENSP00000417404	DOID:2352	"MYDISEASETOKEN and ""MYGENETOKEN"": definite!"
17710673	2	2	ENSP00000417404	DOID:2352	Most cases are homozygous for the C282Y mutation in the MYGENETOKEN gene, but only a minority of homozygotes will ever suffer from clinical MYDISEASETOKEN.
18657084	2	9	ENSP00000417404	DOID:2352	Mutations in MYGENETOKEN associated with MYDISEASETOKEN were present in superdonors at the same frequency as the normal population.
11205685	1	1	ENSP00000417404	DOID:2352	MYDISEASETOKEN: automated detection of the two point mutations in the MYGENETOKEN gene: Cys282Tyr and His63Asp.
17943492	2	2	ENSP00000417404	DOID:2352	A decade has passed since the discovery of the MYDISEASETOKEN gene, MYGENETOKEN, and our understanding of hereditary MYDISEASETOKEN (HH) and iron metabolism in health and a variety of diseases has progressed considerably.
10811057	2	4	ENSP00000333994	DOID:2352	However, the correlation between ferritin iron concentration and individual liver iron concentration was poor in patients with MYDISEASETOKEN (r = 0.63) and patients with MYGENETOKEN (r = 0.57).
10216143	2	6	ENSP00000417404	DOID:2352	"Our results point to genetic forms of MYDISEASETOKEN not associated with MYGENETOKEN and raise the problem of whether non-MYGENETOKEN MYDISEASETOKEN in Italy is related to the ""juvenile"" form."
16419611	2	3	ENSP00000417404	DOID:2352	In 1996 the gene responsible for MYDISEASETOKEN was detected--the MYGENETOKEN gene and its major mutation C282Y.
12059121	2	9	ENSP00000417404	DOID:2352	Results of this study indicate that many of the symptoms associated with MYDISEASETOKEN are common among MYGENETOKEN wild types and that clinical penetrance of the C282Y/C282Y genotype in regard to these symptoms is low.
10084283	2	2	ENSP00000417404	DOID:2352	One example is the discovery of the MYGENETOKEN gene that is mutated in patients suffering from hereditary MYDISEASETOKEN.
12145827	1	1	ENSP00000417404	DOID:2352	Differential MYGENETOKEN allele expression in MYDISEASETOKEN heterozygotes.
14633776	2	9	ENSP00000417404	DOID:2352	Evidence regarding the biochemical and clinical penetrance of MYDISEASETOKEN due to mutations of the MYGENETOKEN gene is rapidly accumulating.
19008010	1	1	ENSP00000417404	DOID:2352	Severity of iron overload of proband determines serum ferritin levels in families with MYGENETOKEN-related MYDISEASETOKEN: the MYDISEASETOKEN FAmily Study.
10205270	2	2	ENSP00000417404	DOID:2352	Affected members in families with JH do not show linkage to chromosome 6p and do not have mutations in the MYGENETOKEN gene that lead to the common hereditary MYDISEASETOKEN.
10575542	1	1	ENSP00000417404	DOID:2352	Haplotype analysis of the MYGENETOKEN gene: implications for the origins of MYDISEASETOKEN related mutations.
17373275	2	3	ENSP00000417404	DOID:2352	The MYGENETOKEN C282Y +/+ mutation is responsible for the most frequent type of MYDISEASETOKEN in France.
9931446	1	1	ENSP00000417404	DOID:2352	Cloning, sequencing and characterization of the rat hereditary MYDISEASETOKEN promoter: comparison of the human, mouse and rat MYGENETOKEN promoter regions.
14633776	2	7	ENSP00000222304	DOID:2352	A more severe, juvenile form of MYDISEASETOKEN results from mutations of the gene encoding MYGENETOKEN or of a not-yet-identified gene on chromosome 1q.
28358914	2	1	ENSP00000417404	DOID:2352	Human MYDISEASETOKEN protein (MYGENETOKEN) is involved in iron metabolism.
11436126	2	1	ENSP00000417404	DOID:2352	Hereditary MYDISEASETOKEN is an inherited disorder characterised by an excessive iron absorption from the diet and is associated with several MYGENETOKEN gene mutations.
12547233	1	1	ENSP00000261024	DOID:2352	Dominant MYDISEASETOKEN due to N144H mutation of MYGENETOKEN: clinical and biological characteristics.
16216474	1	1	ENSP00000417404	DOID:2352	Frequency of MYDISEASETOKEN gene (MYGENETOKEN) mutations in Russian healthy women and patients with estrogen-dependent cancers.
17729390	2	1	ENSP00000417404	DOID:2352	Non-MYGENETOKEN hereditary MYDISEASETOKEN (HH) refers to a genetically heterogeneous group of iron overload disorders that are unlinked to mutations in the MYGENETOKEN gene.
11358390	2	5	ENSP00000223051	DOID:2352	25, 14-15, 2000) identified a stop mutation (exon 6 nt 750 C --&gt; T, Y250X) on the MYGENETOKEN (MYGENETOKEN) gene in two unrelated Sicilian families with hereditary MYDISEASETOKEN.
22362121	2	2	ENSP00000417404	DOID:2352	The presence of MYDISEASETOKEN gene (MYGENETOKEN) mutations might exacerbate iron toxicity in the post-transplant setting.
14648375	2	1	ENSP00000417404	DOID:2352	MYDISEASETOKEN is usually inherited in an autosomal recessive mode and associated with missense mutations in the MYDISEASETOKEN gene (MYGENETOKEN), an HLA class 1 related gene.
11686223	1	1	ENSP00000417404	DOID:2352	Mutation analysis of the MYGENETOKEN gene in German MYDISEASETOKEN patients and controls using automated SSCP-based capillary electrophoresis and a new PCR-ELISA technique.
11722599	2	9	ENSP00000417404	DOID:2352	These results suggest that a lower peripheral blood lymphocyte count is associated with a greater degree of iron loading in MYGENETOKEN MYDISEASETOKEN but not in African iron overload, and they support the notion that the lymphocyte count may serve as a marker of a non-MYGENETOKEN gene that influences the clinical expression of MYGENETOKEN MYDISEASETOKEN.
17002922	2	1	ENSP00000417404	DOID:2352	Homozygosity for the C282Y mutation of the MYDISEASETOKEN gene on chromosome 6p (MYGENETOKEN) is a common genetic trait that increases susceptibility to iron overload.
16848710	2	6	ENSP00000222304	DOID:2352	At the opposite side of the spectrum, MYGENETOKEN deficiency appears to be the ultimate cause of most forms of MYDISEASETOKEN, either due to mutations in the MYGENETOKEN gene itself or due to mutations in the regulators of MYGENETOKEN synthesis.
12482411	2	14	ENSP00000417404	DOID:2352	The present cases do not have MYGENETOKEN genotypes typical of MYDISEASETOKEN diagnosed in adults.
25015053	1	1	ENSP00000417404	DOID:2352	MYGENETOKEN-related MYDISEASETOKEN risk mutations  in Latvian population.
18363869	2	6	ENSP00000417404	DOID:2352	HLA haplotypes and MYGENETOKEN mutations were studied in MYDISEASETOKEN patients with present or past parental origin in a sparsely populated (1/km(2)) rural district (n = 8366 in the year of 2005), in central Sweden.
11478357	2	1	ENSP00000417404	DOID:2352	MYDISEASETOKEN associated with mutations in the MYGENETOKEN gene is the most common inherited disorder in Caucasian populations.
17289614	2	7	ENSP00000417404	DOID:2352	Some data support the possibility that these common forms of hereditary MYDISEASETOKEN mutation (MYGENETOKEN-C282Y and MYGENETOKEN-H63D)--even in the heterozygote form--elevate the tissue level of iron without manifesting the phenotype of classical hereditary MYDISEASETOKEN.
9328324	1	1	ENSP00000417404	DOID:2352	Clinical and family studies in genetic MYDISEASETOKEN: microsatellite and MYGENETOKEN studies in five atypical families.
17376729	2	3	ENSP00000417404	DOID:2352	MYGENETOKEN-deficient mice develop iron overload indicating a central role of the protein in the pathogenesis of hereditary MYDISEASETOKEN type I.
14614395	2	1	ENSP00000417404	DOID:2352	The purpose of this study was to estimate analytic sensitivity and specificity of MYGENETOKEN testing for C282Y homozygosity in the hypothetical setting of population screening for MYDISEASETOKEN.
10348824	2	1	ENSP00000417404	DOID:2352	Most patients with genetic MYDISEASETOKEN are homozygous for a single mutation of the MYGENETOKEN gene (C282Y).
15610558	2	5	ENSP00000337014	DOID:2352	We evaluated the genomic DNA of 241 Alabama white and 124 African American adults who reported no history of MYDISEASETOKEN or iron overload to detect MYGENETOKEN missense mutations I222N and G320V using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique.
10930379	2	1	ENSP00000417404	DOID:2352	Most MYDISEASETOKEN patients of Northern European descent are homozygous for the C282Y mutation of MYGENETOKEN gene.
17106152	2	2	ENSP00000417404	DOID:2352	The major mutation of MYDISEASETOKEN in Celtic ancestry, C282Y of MYGENETOKEN, was reported in a Japanese patient.
10832943	1	1	ENSP00000417404	DOID:2352	Use of MYGENETOKEN mutation analysis for hereditary MYDISEASETOKEN: the need for physician education in the translation of basic science to clinical practice.
25737209	2	7	ENSP00000222304	DOID:2352	The update on MYGENETOKEN centered mechanisms of iron metabolism and their clinical perspective in MYDISEASETOKEN will be discussed in this review.
22674401	2	7	ENSP00000417404	DOID:2352	After the introduction of the MYGENETOKEN genetic test an earlier diagnosis after first onset of MYDISEASETOKEN-associated clinical features was observed between 2006 and 2009 vs.
17540536	2	1	ENSP00000417404	DOID:2352	Hereditary iron overload is mainly due to mutations of the MYGENETOKEN gene, implicated in most cases of hereditary MYDISEASETOKEN.
12707220	1	1	ENSP00000417404	DOID:2352	The MYGENETOKEN Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary MYDISEASETOKEN.
22504868	2	1	ENSP00000417404	DOID:2352	Mutations in the MYDISEASETOKEN gene (MYGENETOKEN) influence iron status in the general population of Northern Europe, and excess iron is associated with the impairment of spermatogenesis.
16417669	2	6	ENSP00000385638	DOID:2352	One or more MRC complex activities (expressed as ratios relative to citrate synthase and/or complex II activity) were less than 50% of control mean activity in 11/20 patients (including patients with deficiencies of pyruvate dehydrogenase complex, pantothenate kinase, holocarboxylase synthetase, long-chain MYGENETOKEN, molybdenum co-factor, and neonatal MYDISEASETOKEN).
19058322	1	1	ENSP00000417404	DOID:2352	Function of the MYDISEASETOKEN protein MYGENETOKEN: Lessons from animal models.
11313312	2	1	ENSP00000417404	DOID:2352	Overexpression of duodenal divalent metal transporter (DMT1) messenger RNA occurs in MYDISEASETOKEN and MYGENETOKEN-knockout mice, suggesting that DMT1 mediates enhanced absorption of iron; however, increased expression of functional DMT1 protein has yet to be substantiated.
24282517	2	1	ENSP00000417404	DOID:2352	Hereditary MYDISEASETOKEN (HH) is a recessively inherited disorder of iron overload occurring commonly in subjects homozygous for the C282Y mutation in MYGENETOKEN gene localized on chromosome 6p21.3 in linkage disequilibrium with the human leukocyte antigen (HLA)-A locus.
14635204	2	1	ENSP00000417404	DOID:2352	Three polymorphic gene mutations in the human MYDISEASETOKEN (MYGENETOKEN) gene (C282Y, H63D, S65C) are associated with non-transfusion-related iron overload in Caucasians.
12714823	2	1	ENSP00000417404	DOID:2352	The frequencies of the hereditary MYDISEASETOKEN gene (MYGENETOKEN) mutations C282Y and H63D vary between different populations.
12902032	2	2	ENSP00000417404	DOID:2352	We studied the role of mutations in the MYDISEASETOKEN gene MYGENETOKEN in PD and other parkinsonism (non-PD PS) in two population-based series.
16868025	2	2	ENSP00000337014	DOID:2352	Mutations in this gene have been linked to the severe MYDISEASETOKEN, juvenile MYDISEASETOKEN, although the mechanisms of action of MYGENETOKEN in iron metabolism are unknown.
17945001	2	1	ENSP00000417404	DOID:2352	MYGENETOKEN disruption in mouse leads to experimental MYDISEASETOKEN by a mechanism that remains elusive.
20979574	1	3	ENSP00000417404	DOID:2352	They received brief information on MYGENETOKEN-HH and were assessed for the signs and symptoms of MYDISEASETOKEN.
12714823	1	1	ENSP00000417404	DOID:2352	Prevalence of MYDISEASETOKEN gene (MYGENETOKEN) mutations in Greece.
25075539	2	3	ENSP00000417404	DOID:2352	Most human hereditary MYDISEASETOKEN cases (up to 90%) are caused by a point mutation in the MYGENETOKEN gene, resulting in a C282Y substitution leading to iron accumulation.
12712916	2	2	ENSP00000417404	DOID:2352	The aim of this study was to specify the relationship between iron overload, polymetabolic syndrome, MYGENETOKEN mutations of primary MYDISEASETOKEN and steatosis.
17194693	1	1	ENSP00000417404	DOID:2352	Consequences of expressing mutants of the MYDISEASETOKEN gene (MYGENETOKEN) into a human neuronal cell line lacking endogenous MYGENETOKEN.
21959608	2	2	ENSP00000417404	DOID:2352	It is characterized by a variable prevalence of mutations in the MYDISEASETOKEN gene (MYGENETOKEN) in different countries and a complex relationship between the MYGENETOKEN genotype and the HH phenotype.
19589941	1	1	ENSP00000222304	DOID:2352	Hereditary MYDISEASETOKEN due to resistance to MYGENETOKEN: high MYGENETOKEN concentrations in a family with C326S ferroportin mutation.
10491369	2	1	ENSP00000417404	DOID:2352	Background-The genetic background of hereditary MYDISEASETOKEN (HH) is homozygosity for a cysteine-to-tyrosine transition at position 282 in the MYGENETOKEN gene.
24368960	2	12	ENSP00000417404	DOID:2352	The MYGENETOKEN gene H63D mutation underlies Hereditary MYDISEASETOKEN (HH), which needs treatment to prevent organ damages by iron overload.
16138214	1	1	ENSP00000417404	DOID:2352	MYDISEASETOKEN (MYGENETOKEN) gene mutations in Brazilian chronic hemodialysis patients.
11199371	1	2	ENSP00000417404	DOID:2352	Excessive oral iron intake may lead to secondary MYDISEASETOKEN even in MYGENETOKEN C282Y mutation negative subjects.
19453575	2	3	ENSP00000417404	DOID:2352	It was reported that individual immunological profile of CD8+ T-lymphocytes may have a modifying effect on the severity of iron overload in MYGENETOKEN homozygous MYDISEASETOKEN patients, with low numbers being negatively correlated with the total amount of body iron stores.
17019598	2	11	ENSP00000250971	DOID:2352	MYGENETOKEN secretory capacity improves after normalisation of iron stores in subjects with hereditary MYDISEASETOKEN.
19667680	2	4	ENSP00000222304	DOID:2352	Dr Andrews also examines the link between ACD and hereditary MYDISEASETOKEN, 2 disorders that on the surface may seem quite different but have in common the involvement of MYGENETOKEN in their pathogenesis.
11379346	2	4	ENSP00000342267	DOID:2352	Heterozygotes were identified by mailing individuals homozygous for hereditary MYDISEASETOKEN questionnaires concerning the number of siblings born alive and the number of miscarriages suffered by their mothers (predominantly heterozygotes, or MYGENETOKEN).
28115312	2	4	ENSP00000337014	DOID:2352	Male and female wild-type and MYGENETOKEN-null mice were injected and fed with a high-iron diet, respectively, to develop secondary iron overload and genetic MYDISEASETOKEN.
6381191	2	5	ENSP00000250971	DOID:2352	MYGENETOKEN concentrations increased to significantly higher levels in patients with idiopathic MYDISEASETOKEN than in the control subjects from 30 to 180 min after the glucose load (p less than or equal to 0.01), while fasting MYGENETOKEN concentrations were not significantly different (p greater than 0.05).
19796184	1	1	ENSP00000337014	DOID:2352	Juvenile MYDISEASETOKEN due to homozygosity for the G320V mutation in the MYGENETOKEN gene with fatal outcome.
19400694	2	4	ENSP00000222304	DOID:2352	Except for inherited defects of ferroportin and MYGENETOKEN itself, all forms of MYDISEASETOKEN appear to arise from MYGENETOKEN dysregulation.
27007796	1	1	ENSP00000222304	DOID:2352	MYGENETOKEN Gene Mutation Associated with Juvenile MYDISEASETOKEN in Brazilian Patients.
19399775	2	2	ENSP00000222304	DOID:2352	MYGENETOKEN concentrations are increased in inflammation and suppressed in MYDISEASETOKEN.
23156704	2	1	ENSP00000250971	DOID:2352	MYDISEASETOKEN in bottlenose dolphins (Tursiops truncatus) is associated with high postprandial plasma MYGENETOKEN levels, suggestive of insulin resistance.
7942036	2	2	ENSP00000333994	DOID:2352	This article describes two patients with MYGENETOKEN and MYDISEASETOKEN complicated by Klebsiella pneumoniae liver abscess.
26385212	2	5	ENSP00000333994	DOID:2352	Overall, highest assay levels were observed for patients with untreated hereditary MYDISEASETOKEN and MYGENETOKEN, patients with transfusion-dependent myelodysplastic syndromes and patients with transfusion-dependent and chelated MYGENETOKEN.
23105707	2	3	ENSP00000447173	DOID:2352	Three genes related to lead metabolism, exhibiting polymorphism have already been demonstrated-DeltaALA-dehydratase, MYGENETOKEN gene and MYDISEASETOKEN gene.
19234060	2	2	ENSP00000337014	DOID:2352	Knockout (KO) mice lacking MYGENETOKEN (Hjv-/-) spontaneously load with dietary iron and, therefore, present a model for hereditary MYDISEASETOKEN (HH).
12134060	1	1	ENSP00000223051	DOID:2352	Targeted mutagenesis of the murine MYGENETOKEN gene produces MYDISEASETOKEN.
16054062	2	3	ENSP00000222304	DOID:2352	If ferroportin is the major cellular iron exporter, ineffective MYGENETOKEN function could explain manifestations of human MYDISEASETOKEN disorders.
10675018	2	2	ENSP00000308541	DOID:2352	The mutations causing MYDISEASETOKEN and thrombogenetic diseases (factor V Leiden mutation and MYGENETOKEN mutation) are well defined.
17557668	1	1	ENSP00000222304	DOID:2352	[Hereditary MYDISEASETOKEN: novel genes, novel diseases and MYGENETOKEN].
11431687	2	4	ENSP00000261024	DOID:2352	We report that a mutation in the gene encoding Solute Carrier family 11, member A3 (MYGENETOKEN), also known as ferroportin, is associated with autosomal dominant MYDISEASETOKEN.
16424658	2	1	ENSP00000223051	DOID:2352	We report three mutations of MYGENETOKEN (MYGENETOKEN)--R396X (exon 9; nt 1186C--&gt;T), R455Q (exon 10; nt 1364G--&gt;A) and G792R (exon 18; nt 2374G--&gt;A)--in a man of Scottish descent with MYDISEASETOKEN and severe iron overload.
18492090	2	8	ENSP00000337014	DOID:2352	We conclude that homozygosity for MYGENETOKEN R54X accounts for his severe, early age-of-onset MYDISEASETOKEN; his phenotype was probably modified by serial phlebotomy therapy.
23333676	2	3	ENSP00000223051	DOID:2352	To identify features that are common across different forms of MYDISEASETOKEN, we used microarray and real-time reverse transcription polymerase chain reaction (RT-PCR) to assess brain transcriptome profiles of MYGENETOKEN mutant mice (MYGENETOKEN(mut)), a model of a rare type of hereditary MYDISEASETOKEN, relative to wildtype control mice.
25635054	2	1	ENSP00000223051	DOID:2352	Mutations in MYGENETOKEN (MYGENETOKEN) cause a rare form of the hereditary MYDISEASETOKEN, resulting in iron overload predominantly in the liver.
1349563	2	4	ENSP00000366005	DOID:2352	Only one marker presents an unequivocal association with the MYDISEASETOKEN gene and is 100 kb centromeric to MYGENETOKEN.
24003015	2	3	ENSP00000366525	DOID:2352	We report a patient with HHCS who was misdiagnosed and treated as having MYDISEASETOKEN, in whom a heterozygous c.-160A&gt;G mutation was identified in the iron responsive element (IRE) of MYGENETOKEN, causing ferritin synthesis in the absence of iron overload.
26238956	2	5	ENSP00000337014	DOID:2352	This chromosome region contained MYGENETOKEN, a critical gene involved in hereditary MYDISEASETOKEN.
13767975	1	1	ENSP00000369351	DOID:2352	Cardiac complications of chronic, severe, MYGENETOKEN with MYDISEASETOKEN.
15194541	1	1	ENSP00000337014	DOID:2352	Prevalence of the G320V mutation of the MYGENETOKEN gene, associated with juvenile MYDISEASETOKEN, in Greece.
10681454	1	1	ENSP00000223051	DOID:2352	MYGENETOKEN: continued expression in mouse liver in the face of iron overload and in hereditary MYDISEASETOKEN.
18590684	2	1	ENSP00000222304	DOID:2352	MYGENETOKEN, the systemic regulator of iron homeostasis is activated by proteins responsible for hereditary MYDISEASETOKEN, bone morphogenetic proteins (BMPs), and inflammatory cytokines.
18105260	1	1	ENSP00000369351	DOID:2352	MYDISEASETOKEN with aplastic or MYGENETOKEN.
22383097	1	1	ENSP00000223051	DOID:2352	Disruption of MYDISEASETOKEN protein and MYGENETOKEN causes iron-induced liver injury in mice.
16424658	1	1	ENSP00000223051	DOID:2352	MYDISEASETOKEN and severe iron overload associated with compound heterozygosity for MYGENETOKEN R455Q and two novel mutations MYGENETOKEN R396X and G792R.
17019598	2	1	ENSP00000250971	DOID:2352	We recently demonstrated that humans with hereditary MYDISEASETOKEN have decreased MYGENETOKEN secretory capacity with a compensatory increase in insulin sensitivity.
19622835	2	1	ENSP00000222304	DOID:2352	Impaired regulation of MYGENETOKEN expression in response to iron loading appears to be the pathogenic mechanism for hereditary MYDISEASETOKEN.
15998830	2	1	ENSP00000337014	DOID:2352	Mutations in a recently identified gene MYGENETOKEN (also called MYGENETOKEN, or repulsive guidance molecule C, MYGENETOKEN) are the major cause of juvenile MYDISEASETOKEN (JH).
16364680	2	6	ENSP00000263735	DOID:2352	For DNs and hereditary MYDISEASETOKEN, MYGENETOKEN expression was found in 10 and 50% (3/30 and 2/4), respectively.
7649553	2	1	ENSP00000366005	DOID:2352	The gene responsible for hereditary MYDISEASETOKEN has been shown to be closely linked to the MYGENETOKEN and D6S105 loci on the short arm of chromosome 6.
12469120	1	1	ENSP00000222304	DOID:2352	Mutant antimicrobial peptide MYGENETOKEN is associated with severe juvenile MYDISEASETOKEN.
15610558	2	1	ENSP00000337014	DOID:2352	Homozygosity or compound heterozygosity for coding region mutations of the MYGENETOKEN gene (MYGENETOKEN) in whites is a cause of early age-of-onset iron overload (juvenile MYDISEASETOKEN), and of MYDISEASETOKEN phenotypes in some young or middle-aged adults.
15760675	2	3	ENSP00000398698	DOID:2352	We performed a review of published studies linking IHD with gene polymorphisms of the MHC molecules tumor necrosis factor (MYGENETOKEN)-alpha and -beta, the class II DR human leukocyte antigens, heat shock protein 70-1, MYDISEASETOKEN related gene, and complement C4.
23464809	2	2	ENSP00000337014	DOID:2352	Mutations in MYGENETOKEN cause juvenile MYDISEASETOKEN, a rapidly progressing iron overload disorder in humans.
8328453	2	1	ENSP00000366005	DOID:2352	The MYDISEASETOKEN (HC) gene is known to be linked to MYGENETOKEN (6p21.3); however, its precise location has been difficult to determine because of a lack of additional highly polymorphic markers for this region.
17557668	2	5	ENSP00000222304	DOID:2352	Plasma MYGENETOKEN concentration is elevated in body iron excess and by inflammatory stimuli, and is lowered in erythroid iron demand, hypoxia and most types of hereditary MYDISEASETOKEN.
15198949	1	1	ENSP00000222304	DOID:2352	Severe MYDISEASETOKEN in a Portuguese family associated with a new mutation in the 5'-UTR of the MYGENETOKEN gene.
19399775	2	9	ENSP00000222304	DOID:2352	Urine MYGENETOKEN levels were 10 nmol/mmol creatinine in healthy controls, with reduced levels in hereditary MYDISEASETOKEN (P &lt; 0.000005) and elevated levels in inflammation (P &lt; 0.0007).
15737887	2	4	ENSP00000222304	DOID:2352	A milestone was the discovery that MYGENETOKEN, the key iron regulator in mice, is the gene mutated in the most severe, juvenile form of MYDISEASETOKEN.
24847265	2	5	ENSP00000223051	DOID:2352	However, MYGENETOKEN null mice as well as MYGENETOKEN MYDISEASETOKEN patients do not show defective erythropoiesis and tolerate repeated phlebotomy.
12940442	2	4	ENSP00000398698	DOID:2352	Our aim was to study the role of MYGENETOKEN and its promoter polymorphisms in the phenotypic expression of MYDISEASETOKEN in individuals with and without the C282Y mutation.
13302168	1	2	ENSP00000369351	DOID:2352	I.  MYDISEASETOKEN and MYGENETOKEN.
10802645	1	1	ENSP00000223051	DOID:2352	The gene MYGENETOKEN is mutated in a new type of MYDISEASETOKEN mapping to 7q22.
23169885	2	13	ENSP00000337014	DOID:2352	Similarly, RPE cells from MYGENETOKEN (MYGENETOKEN)-knockout mice, another model of MYDISEASETOKEN, also had increased expression of GLUTs, HDACs, and DNMTs.
19625109	2	1	ENSP00000222304	DOID:2352	In the last few years, biochemical and molecular study of the various types of MYDISEASETOKEN have established that the MYGENETOKEN peptide is the central regulator of iron absorption.
18584923	2	7	ENSP00000223051	DOID:2352	Juvenile MYDISEASETOKEN (type 2) and type 3 MYDISEASETOKEN (mutation of the MYGENETOKEN) are very uncommon.
15486069	2	2	ENSP00000222304	DOID:2352	Recent evidence indicates that certain forms of hereditary MYDISEASETOKEN are caused by MYGENETOKEN deficiency.
9306096	2	1	ENSP00000366005	DOID:2352	Genes that predispose to MYDISEASETOKEN are though to be located within the several megabases telomeric of MYGENETOKEN.
11472372	2	1	ENSP00000264613	DOID:2352	As MYGENETOKEN (Cp) seems to be involved in iron mobilization, serum Cp levels were measured in 35 patients with hereditary MYDISEASETOKEN (HH), 12 with acquired iron overload (AIO) and 36 healthy subjects.
14982867	1	1	ENSP00000337014	DOID:2352	Genetic abnormalities and juvenile MYDISEASETOKEN: mutations of the MYGENETOKEN gene encoding MYGENETOKEN.
3475981	1	1	ENSP00000366005	DOID:2352	A study of 609 HLA haplotypes marking for the MYDISEASETOKEN gene: (1) mapping of the gene near the MYGENETOKEN locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of MYDISEASETOKEN-HLA association.
21675259	2	4	ENSP00000308541	DOID:2352	Eleven polymorphisms in 7 genes coding hemostasis protein synthesis were investigated: V Leiden G1691A factor, G20210A MYGENETOKEN, C677T methylentetrahydrofolatreductase, A1298C methylentetrahydrofolatreductase, type 1 plasminogen activator inhibitor, 4G/5G promoter region, XIII V34L coagulation factor, IIIa L33P thrombocytic glycoprotein, C282Y MYDISEASETOKEN, G854A beta-fibrinogen, G455A beta-fibrinogen, C249T beta-fibrinogen.
21136275	2	2	ENSP00000222304	DOID:2352	Changes in the expression of MYGENETOKEN are known to be the key pathogenic factors in hereditary MYDISEASETOKEN and are associated with infection and inflammation.
24393578	2	4	ENSP00000222304	DOID:2352	However, the emerging details of the physiology of MYGENETOKEN, the key hormone in iron recycling, suggest a resolution of the apparent paradox of an important role for iron in atherogenesis in the possible absence of increased plaque burden in most types of hereditary MYDISEASETOKEN.
11358390	2	18	ENSP00000223051	DOID:2352	Thus, MYGENETOKEN mutations are not responsible for MYDISEASETOKEN in non-C282Y homozygous patients of our area.
17188970	1	1	ENSP00000222304	DOID:2352	Increased expression of MYGENETOKEN in obese patients: impact on phenotypic expression of MYDISEASETOKEN and pathophysiology of dysmetabolic iron overload syndrome.
20039160	2	9	ENSP00000261024	DOID:2352	Type 4 MYDISEASETOKEN follows an autosomal dominant trait; the corresponding mutation affects the basolateral iron carrier MYGENETOKEN.
15818147	2	3	ENSP00000222304	DOID:2352	For example, the role of MYGENETOKEN dysregulation in MYDISEASETOKEN has been a surprising discovery that provides some mechanistic understanding for the increased iron absorption that is present in this disorder.
11358391	1	1	ENSP00000223051	DOID:2352	Commentary: mutations of MYGENETOKEN (Trf-2) and MYDISEASETOKEN.
16537241	1	1	ENSP00000222304	DOID:2352	MYDISEASETOKEN, MYGENETOKEN and disorders of iron metabolism: fields of substantial clinical relevance and current advances.
15099344	1	1	ENSP00000222304	DOID:2352	A homozygous MYGENETOKEN mutation in a multiply consanguineous family with pseudo-dominant juvenile MYDISEASETOKEN.
15685557	2	11	ENSP00000223051	DOID:2352	A 21-year-old brother with a milder phenotype resembling classic adult-onset hereditary MYDISEASETOKEN carried only the Q317X serum MYGENETOKEN homozygote mutation.
1558977	2	7	ENSP00000398698	DOID:2352	We conclude that release of MYGENETOKEN by monocytes may be selectively impaired in hereditary MYDISEASETOKEN.
6167540	2	5	ENSP00000366005	DOID:2352	Thus, the MYDISEASETOKEN locus maps in close proximity to the MYGENETOKEN locus.
12150153	1	1	ENSP00000223051	DOID:2352	Mutation analysis of MYGENETOKEN in patients with atypical MYDISEASETOKEN.
15703644	2	6	ENSP00000222304	DOID:2352	Other data suggests that the altered regulation of the peptide MYGENETOKEN may play a pivotal role in the development of the iron overload phenotype in patients with MYDISEASETOKEN.
15124225	2	5	ENSP00000223051	DOID:2352	The development of these mice will provide new models for type 3 MYDISEASETOKEN and assist in determining the role of MYGENETOKEN in iron metabolism.
14656876	1	1	ENSP00000222304	DOID:2352	MYGENETOKEN, a candidate modifier of the MYDISEASETOKEN phenotype in mice.
12091366	2	6	ENSP00000261024	DOID:2352	We report the finding of a novel mutation (V162del) in MYGENETOKEN in an Australian family with autosomal dominant MYDISEASETOKEN.
24714983	2	2	ENSP00000261024	DOID:2352	MYGENETOKEN mutations fall into two functional categories (loss- versus gain-of-function) underlying two distinct clinical entities (MYDISEASETOKEN type 4A versus type 4B).
28425416	1	1	ENSP00000355607	DOID:2352	MYGENETOKEN rs11558492 is not a Major Modifier of Iron Status: Study of Italian MYDISEASETOKEN Patients and Blood Donors.
15147384	1	1	ENSP00000223051	DOID:2352	Early onset hereditary MYDISEASETOKEN resulting from a novel MYGENETOKEN gene nonsense mutation (R105X) in two siblings of north French descent.
3504294	1	1	ENSP00000250971	DOID:2352	[Evaluation of the endocrine function and study of the anti-MYGENETOKEN antibodies in MYDISEASETOKEN].
12091366	2	5	ENSP00000261024	DOID:2352	Recently, 2 mutations in the MYGENETOKEN gene, which encodes the iron transport protein MYGENETOKEN, have been implicated in families with autosomal dominant MYDISEASETOKEN from the Netherlands and Italy.
2219895	2	2	ENSP00000366005	DOID:2352	The gene that is abnormal in MYDISEASETOKEN is found on the short arm of chromosome 6 in close proximity (approximately 1 centimorgan) to MYGENETOKEN, but the product coded for by that gene is unknown.
19393287	2	2	ENSP00000222304	DOID:2352	Inappropriately low MYGENETOKEN expression is implicated in the pathogenesis of hereditary MYDISEASETOKEN and iron-loading anemias, like the thalassemias.
12809944	1	1	ENSP00000223051	DOID:2352	AVAQ 594-597 deletion of the MYGENETOKEN gene in a Japanese family with MYDISEASETOKEN.
12618377	2	9	ENSP00000364731	DOID:2352	Unambiguous typing was achieved for clinically relevant loci within the MYGENETOKEN and MYDISEASETOKEN genes.
22392951	2	6	RMRP	DOID:2352	Before diagnosing MYGENETOKEN, however, it is necessary to rule out a pituitary tumor or pituitary infiltration by imaging studies, juvenile MYDISEASETOKEN, and a systemic disorder that, by undermining nutritional status, could affect gonadotropin secretion and pubertal development.
2741950	2	5	ENSP00000366005	DOID:2352	In addition, HLA-A2 and -B12 were in significant linkage disequilibrium in patients but not in controls, which may indicate a new mutation or recent recombination between MYGENETOKEN and MYDISEASETOKEN either in our patient group or in the founding population.
19625109	1	1	ENSP00000222304	DOID:2352	[Role of MYGENETOKEN in the pathogenesis of MYDISEASETOKEN].
18293685	2	5	ENSP00000337014	DOID:2352	The Online Mendelian Inheritance in Man database has lists four types of hereditary MYDISEASETOKEN, each of them caused by a different gene mutation (hepcidine, MYGENETOKEN, transferring receptor 2, ferroportin).
10802645	2	4	ENSP00000223051	DOID:2352	7). Here we report a new locus (MYGENETOKEN) on 7q22 and show that a homozygous nonsense mutation in the gene encoding MYGENETOKEN (MYGENETOKEN) is found in people with MYDISEASETOKEN that maps to MYGENETOKEN.
23160508	2	3	ENSP00000369351	DOID:2352	We report a case of a 78- year-old man with MYDISEASETOKEN who developed MYGENETOKEN with excess of blasts.
22896664	2	3	ENSP00000337014	DOID:2352	We used MYGENETOKEN-knockout (MYGENETOKEN(-/-)) mice to examine whether MYDISEASETOKEN restores the virulence defects of nonpigmented Y. pestis.
23996780	1	1	ENSP00000222304	DOID:2352	MYGENETOKEN in MYDISEASETOKEN: the message or the messenger?
3359685	2	1	ENSP00000366005	DOID:2352	MYGENETOKEN, -B, -C and -DR antigens were determined in 70 unrelated Danish patients with idiopathic MYDISEASETOKEN.
6381191	2	8	ENSP00000250971	DOID:2352	Since pancreatic insulin secretion (C-peptide), glucagon secretion, and the entero-insulinar axis (GIP) are not impaired in these non-cirrhotic patients with idiopathic MYDISEASETOKEN, iron accumulation in the hepatocytes may be responsible for the impaired MYGENETOKEN effect and may cause impaired hepatic MYGENETOKEN extraction.
17339196	2	2	ENSP00000337014	DOID:2352	The child was found to have a combination of a novel R176C mutation together with the G320V mutation in the juvenile MYDISEASETOKEN gene (MYGENETOKEN).
16409153	2	3	ENSP00000222304	DOID:2352	MYGENETOKEN, with its cognate receptor, ferroportin, has emerged as a central regulator of iron homeostasis; all of the known causes of MYDISEASETOKEN appear to prevent this system from functioning normally.
16446107	2	12	ENSP00000332369	DOID:2352	Thus, MYGENETOKEN mutations might contribute to more severe iron loading in persons with primary MYDISEASETOKEN.
11358390	1	1	ENSP00000223051	DOID:2352	MYGENETOKEN gene and non-C282Y homozygous patients with MYDISEASETOKEN.
23600741	1	1	ENSP00000223051	DOID:2352	Variable age of onset and clinical severity in MYGENETOKEN related MYDISEASETOKEN: novel observations.
16868025	2	9	ENSP00000337014	DOID:2352	Our results define a series of biosynthetic steps leading to the normal production of different MYGENETOKEN isoforms in cells, and provide a framework for understanding the biochemical basis of defects in the maturation of MYGENETOKEN in juvenile MYDISEASETOKEN.
15713792	2	2	ENSP00000222304	DOID:2352	To understand the mechanisms whereby MYGENETOKEN controls iron homeostasis in vivo, we have analyzed the level of iron-related proteins by Western blot and immunohistochemistry in MYGENETOKEN-deficient mice, a mouse model of severe MYDISEASETOKEN.
22990014	2	1	ENSP00000222304	DOID:2352	The deficiency of MYGENETOKEN, the hormone that controls iron absorption and its tissue distribution, is the cause of iron overload in nearly all forms of hereditary MYDISEASETOKEN and in untransfused iron-loading anemias.
17229647	1	1	ENSP00000222304	DOID:2352	Molecular mechanism of MYGENETOKEN deficiency in a patient with juvenile MYDISEASETOKEN.
23985001	2	1	ENSP00000222304	DOID:2352	Hereditary MYDISEASETOKEN is an inherited iron overload disorder caused by inappropriately low MYGENETOKEN secretion leading to increased duodenal absorption of dietary iron, most commonly in C282Y homozygous individuals.
27667164	2	8	ENSP00000222304	DOID:2352	In conclusion, increased intracellular iron content in recombinant cells did not increase MYGENETOKEN responses compared to wild-type cells, resembling MYDISEASETOKEN.
27445333	1	1	ENSP00000261024	DOID:2352	Non-mutagenic Suppression of Enterocyte MYGENETOKEN by Chemical Ribosomal Inactivation via p38 Mitogen-activated Protein Kinase (MAPK)-mediated Regulation: EVIDENCE FOR ENVIRONMENTAL MYDISEASETOKEN.
22924847	2	6	ENSP00000337014	DOID:2352	Two of the three patients with the MYGENETOKEN genotype displayed classic MYDISEASETOKEN instead of the juvenile type.
2741950	2	1	ENSP00000366005	DOID:2352	The frequencies of different MYGENETOKEN and -B alleles in 77 Australian patients with MYDISEASETOKEN have been compared with frequencies of HLA alleles not associated with MYDISEASETOKEN in 63 of their heterozygous relatives and with published population frequencies.
15749661	2	3	ENSP00000223051	DOID:2352	This suggests that the MYGENETOKEN gene is involved in MYDISEASETOKEN in Japanese patients.
25152992	1	1	ENSP00000337014	DOID:2352	Juvenile MYDISEASETOKEN associated with heterozygosity for novel MYGENETOKEN mutations and with unknown cofactors.
25441019	1	1	ENSP00000261024	DOID:2352	[Usefulness of a diagnostic algorithm hyperferritinemia: A case report of a Spanish family with hereditary MYDISEASETOKEN and mutation in MYGENETOKEN gene].
19415085	2	9	ENSP00000222304	DOID:2352	The pathogenesis is not fully elucidated but recent reports indicate that the protein MYGENETOKEN (produced in the liver) plays a key role in the development of MYDISEASETOKEN.
21161013	2	7	ENSP00000222304	DOID:2352	MYGENETOKEN has been suggested to act as a modifier gene in genetic MYDISEASETOKEN.
9784832	2	2	ENSP00000366005	DOID:2352	The MYDISEASETOKEN gene is probably located close to the MYGENETOKEN locus on the short arm of chromosome 6.
20887198	2	3	ENSP00000222304	DOID:2352	MYGENETOKEN deficiency results in iron overload in hereditary MYDISEASETOKEN and ineffective erythropoiesis.
10802645	2	3	ENSP00000337014	DOID:2352	A locus for juvenile MYDISEASETOKEN (MYGENETOKEN) maps to 1q (ref.
16407589	2	5	ENSP00000222304	DOID:2352	MYGENETOKEN deficiency due to the dysregulation of its synthesis causes most known forms of MYDISEASETOKEN.
2799116	2	24	ENSP00000369351	DOID:2352	Transfusion MYDISEASETOKEN is the principal risk in MYGENETOKEN: this risk can be prevented by iron chelating agents in patients with frequent blood perfusions.
18450729	1	1	ENSP00000223051	DOID:2352	Early-onset MYDISEASETOKEN caused by a novel combination of MYGENETOKEN mutations(p.R396X/c.1538-2 A&gt;G) in a woman of Italian descent.
9874546	2	1	ENSP00000333994	DOID:2352	To identify the optimal MR imaging technique for diagnosing pituitary iron overload, we compared spin-echo and gradient-echo MR imaging with measurements of pituitary T2 relaxation times in 30 patients with secondary MYDISEASETOKEN due to transfusion-dependent MYGENETOKEN and in 10 healthy volunteers.
3938164	1	1	ENSP00000262544	DOID:2352	Severe MYDISEASETOKEN: the predominant clinical manifestation of MYGENETOKEN.
18287331	2	1	ENSP00000337014	DOID:2352	Juvenile MYDISEASETOKEN is a severe and rapidly progressing hereditary disorder of iron overload, and it is caused primarily by defects in the gene encoding repulsive guidance molecule c/MYGENETOKEN (MYGENETOKEN/MYGENETOKEN), a recently identified protein that undergoes a complicated biosynthetic pathway in muscle and liver, leading to cell membrane-linked single-chain and heterodimeric species, and two secreted single-chain isoforms.
12865285	2	3	ENSP00000261024	DOID:2352	The disorder has similarities to type 4 MYDISEASETOKEN, which is caused by mutations in MYGENETOKEN.
23686013	2	6	ENSP00000222304	DOID:2352	Questions arise from the lack of conservation in Drosophila for key mammalian players, such as ferroportin, MYGENETOKEN and all the components of the MYDISEASETOKEN-related pathway.
16424658	2	4	ENSP00000223051	DOID:2352	We conclude that this patient represents another example of MYDISEASETOKEN due to mutations of the gene encoding MYGENETOKEN.
15897636	1	1	ENSP00000261024	DOID:2352	MYDISEASETOKEN with mutation of the MYGENETOKEN (MYGENETOKEN) gene.
15967692	2	1	ENSP00000337014	DOID:2352	MYGENETOKEN (MYGENETOKEN) is a recently discovered gene responsible for 1q-linked juvenile MYDISEASETOKEN.
21654321	2	3	ENSP00000222304	DOID:2352	Recent studies suggest that iron accumulation in most types of MYDISEASETOKEN is due to deficiency of MYGENETOKEN, a central iron regulator.
2338199	2	9	ENSP00000366005	DOID:2352	The present findings favor a location of the MYDISEASETOKEN locus telomeric to MYGENETOKEN.
7874124	2	1	ENSP00000366005	DOID:2352	The gene for hereditary MYDISEASETOKEN (HC) is linked to MYGENETOKEN and D6S105 on chromosome 6p.
15831700	1	1	ENSP00000222304	DOID:2352	Resistance to MYGENETOKEN is conferred by MYDISEASETOKEN-associated mutations of ferroportin.
18164971	2	1	ENSP00000348068	DOID:2352	Hereditary MYDISEASETOKEN and MYGENETOKEN mutation were reported to affect liver functions.
18445598	2	1	ENSP00000337014	DOID:2352	MYGENETOKEN (MYDISEASETOKEN type 2 gene) is highly expressed in skeletal muscle and liver hepatocytes.
24860505	2	1	ENSP00000337014	DOID:2352	Mutations in MYGENETOKEN (MYGENETOKEN) are the most common cause of the juvenile-onset form of the iron overload disorder hereditary MYDISEASETOKEN.
10950940	2	1	ENSP00000337014	DOID:2352	MYDISEASETOKEN type 2 (MYGENETOKEN) or juvenile MYDISEASETOKEN (JH) is a rare recessive disorder that causes iron overload, characterized by early onset and severe clinical course.
12192634	1	1	ENSP00000369351	DOID:2352	[An older female patient with MYGENETOKEN and MYDISEASETOKEN].
15124225	2	2	ENSP00000223051	DOID:2352	Mutations in MYGENETOKEN lead to type 3 MYDISEASETOKEN in humans.
18094142	1	1	ENSP00000223051	DOID:2352	Defective trafficking and localization of mutated MYGENETOKEN: implications for type 3 hereditary MYDISEASETOKEN.
15935710	2	5	ENSP00000261024	DOID:2352	MYGENETOKEN differs from classical MYDISEASETOKEN in that there is a greater amount of macrophage iron sequestration.
21548776	2	5	ENSP00000222304	DOID:2352	Findings in murine models support the concept that the pathogenesis of nearly all forms of hereditary MYDISEASETOKEN involves inappropriately low expression of MYGENETOKEN.
16111902	2	1	ENSP00000261024	DOID:2352	We report a new mutation, Asn185Asp, in exon 6 of the ferroportin gene (MYGENETOKEN) in 15 members of three successive generations of a Canadian family of Scandinavian origin with autosomal dominant MYDISEASETOKEN.
909547	2	6	ENSP00000366005	DOID:2352	The lod-score value (2.239 for theta = 0.005) in six families available for study further supports the conclusion that a MYDISEASETOKEN gene is closely linked to the MYGENETOKEN locus.
24635876	1	1	ENSP00000337014	DOID:2352	Hereditary MYDISEASETOKEN caused by homozygous MYGENETOKEN mutation evolved through paternal disomy.
15933050	2	10	ENSP00000222304	DOID:2352	The rapid and sustained action of a single dose of MYGENETOKEN makes it an appealing agent for the prevention of iron accumulation in hereditary MYDISEASETOKEN.
21150441	2	4	ENSP00000222304	DOID:2352	These advances have modified our understanding of the pathophysiology of MYDISEASETOKEN, now considered a disorder either due to MYGENETOKEN deficiency or (rarely) due to MYGENETOKEN resistance.
23651750	2	1	ENSP00000337014	DOID:2352	Juvenile MYDISEASETOKEN caused by a homozygous Gly320Val mutation in the haemojuvelin (MYGENETOKEN) gene was diagnosed in a 12-year-old Danish girl and her 10-year-old sister.
28514781	2	3	ENSP00000222304	DOID:2352	Genetic alterations influence the serum MYGENETOKEN concentration, which can lead to an iron overload in tissues, as observed in MYDISEASETOKEN, in which serum MYGENETOKEN or defective MYGENETOKEN synthesis is observed.
26059880	1	1	ENSP00000261024	DOID:2352	Novel gain of function mutation in the MYGENETOKEN gene associated with hereditary MYDISEASETOKEN type 4.
17654685	1	1	ENSP00000369351	DOID:2352	MYDISEASETOKEN-associated gene mutations in patients with myelodysplastic syndromes with MYGENETOKEN with ringed sideroblasts.
14226168	1	1	ENSP00000369351	DOID:2352	LATE CARDIAC COMPLICATIONS OF CHRONIC, SEVERE, MYGENETOKEN WITH MYDISEASETOKEN.
18384687	2	2	ENSP00000337014	DOID:2352	Inactivating mutations in the MYGENETOKEN gene cause juvenile MYDISEASETOKEN (JH), a rapidly progressing MYDISEASETOKEN with severe systemic manifestations.
16099526	2	8	ENSP00000337014	DOID:2352	The age at initial presentation of MYGENETOKEN-MYDISEASETOKEN occurs over a wider range than previously described.
20593054	1	1	ENSP00000337014	DOID:2352	Homozygous G320V mutation in the MYGENETOKEN gene causing juvenile hereditary MYDISEASETOKEN type A.
4053696	2	6	ENSP00000366005	DOID:2352	The results confirm the association between the MYGENETOKEN and B loci and the MYDISEASETOKEN gene.
11984516	2	2	ENSP00000223051	DOID:2352	Type 3 MYDISEASETOKEN, recently described in 4 families, is linked to mutations of the gene encoding MYGENETOKEN on chromosome 7q22.
11472372	1	1	ENSP00000264613	DOID:2352	Reduced serum MYGENETOKEN levels in hereditary MYDISEASETOKEN.
24816001	2	8	ENSP00000366482	DOID:2352	Comorbid MYDISEASETOKEN may worsen MYGENETOKEN symptoms through additive effects on iron metabolism.
27740525	0	25	ENSP00000355607	DOID:2352	MYGENETOKEN variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked MYDISEASETOKEN.
27867027	2	4	ENSP00000222304	DOID:2352	Altered levels of extracellular MYGENETOKEN lead to pathological conditions such as MYDISEASETOKEN and iron loading or, on the other side, iron restrictive anemias.
25737209	2	6	ENSP00000222304	DOID:2352	The majority of the hereditary MYDISEASETOKEN (HH) patients are now shown to have mutations in the genes coding either upstream or downstream proteins of MYGENETOKEN, resulting in iron overload.
12637325	2	3	ENSP00000222304	DOID:2352	Using quantitative reverse transcriptase-polymerase chain reaction (RT-PCR), we determined expression of MYGENETOKEN and the most relevant iron-related genes in liver biopsies from patients with MYDISEASETOKEN and iron-stain-negative control subjects.
26975792	2	1	ENSP00000222304	DOID:2352	MYDISEASETOKEN is now known to be an MYDISEASETOKEN with genetic heterogeneity but with a final common metabolic pathway resulting in inappropriately low production of the hormone MYGENETOKEN.
19234060	2	1	ENSP00000337014	DOID:2352	Mutations in MYGENETOKEN (MYGENETOKEN) cause severe juvenile MYDISEASETOKEN, characterized by iron loading of the heart, liver, and pancreas.
14647275	1	1	ENSP00000337014	DOID:2352	Mutations in MYGENETOKEN cause iron overload in chromosome 1q-linked juvenile MYDISEASETOKEN.
26474245	2	11	ENSP00000222304	DOID:2352	Thirteen patients with a LIC&gt;70 mymol/g were enrolled in further genetic analyses: two unrelated patients bore the MYGENETOKEN:c.-153C&gt;T mutation at the heterozygous state, which is associated with increased risk of IO and severe MYDISEASETOKEN.
15811010	1	1	ENSP00000337014	DOID:2352	MYGENETOKEN gene mutations in European patients with juvenile MYDISEASETOKEN.
16103117	2	16	ENSP00000337014	DOID:2352	Mutations in MYGENETOKEN are implicated in the majority of diagnosed juvenile MYDISEASETOKEN patients.
12940442	2	8	ENSP00000398698	DOID:2352	Additionally, the G/A polymorphisms at position -238 and -308 of the MYGENETOKEN, gene were determined by PCR and RFLP analysis in 178 MYDISEASETOKEN patients and 41 controls.
14630809	1	1	ENSP00000222304	DOID:2352	Screening MYGENETOKEN for mutations in juvenile MYDISEASETOKEN: identification of a new mutation (C70R).
21264406	2	8	ENSP00000368752	DOID:2352	This raises the possibility that MYGENETOKEN(C) levels, or its activity, might regulate the progression of diseases in which altered metal homeostasis is thought to play a pathogenic role such as Alzheimer's, Parkinson's and Wilson's diseases and disorders such as MYDISEASETOKEN.
27740525	1	1	ENSP00000355607	DOID:2352	Previous studies in high and low expressors has demonstrated that a variant in the MYGENETOKEN gene (D519G, Rs11558492, chromosome 1, exon 11) has been associated with severe iron overload in C282Y homozygotes for MYDISEASETOKEN.
15737887	2	5	ENSP00000222304	DOID:2352	This finding indicates a fundamental role of MYGENETOKEN in inhibiting both iron absorption from duodenal cells and iron release from macrophages, and has opened up a new view of MYDISEASETOKEN as a disorder of MYGENETOKEN.
19342951	2	4	ENSP00000222304	DOID:2352	MYGENETOKEN, the iron hormone that is defective in MYDISEASETOKEN, is controlled not only by iron signals but also by a number of circulatory and membrane-associated regulators.
17724144	2	2	ENSP00000222304	DOID:2352	We explored the regulation of MYGENETOKEN by iron in 88 MYDISEASETOKEN patients (61 C282Y/C282Y, 27 C282Y/H63D) and 23 healthy controls by analyzing urinary MYGENETOKEN before and 24 hours after a 65-mg oral iron dose.
17124036	2	7	ENSP00000222304	DOID:2352	Recent studies indicate that MYGENETOKEN deficiency underlies most known forms of hereditary MYDISEASETOKEN.
16257244	2	2	ENSP00000261024	DOID:2352	Hereditary MYDISEASETOKEN may be caused by other genetic mutations including those in the MYGENETOKEN gene.
19383972	1	1	ENSP00000222304	DOID:2352	The molecular basis of MYGENETOKEN-resistant hereditary MYDISEASETOKEN.
18462824	2	6	ENSP00000222304	DOID:2352	Differently from what observed in MYDISEASETOKEN, MYGENETOKEN mRNA did not correlate with urinary MYGENETOKEN.
15138164	2	2	ENSP00000337014	DOID:2352	We report the occurrence of compound heterozygous mutations in MYGENETOKEN (MYGENETOKEN), including a termination codon, in a patient with juvenile MYDISEASETOKEN but no family history of iron disorders.
1633650	2	1	ENSP00000366005	DOID:2352	MYGENETOKEN and -B alleles in 74 Danish patients and 21 homozygous relatives with idiopathic MYDISEASETOKEN (IH) were compared with those in a sample of 1719 chromosomes from healthy Danish control subjects.
10663462	2	2	ENSP00000421655	DOID:2352	We therefore investigated 14 patients with hereditary MYDISEASETOKEN with MRI, CT and transcranial ultrasound (MYGENETOKEN) and examined them neurologically.
12401307	2	5	ENSP00000223051	DOID:2352	MYDISEASETOKEN type 3 is linked to a locus on 7q22 and is due to mutations in the MYGENETOKEN.
17339196	1	1	ENSP00000337014	DOID:2352	Juvenile MYDISEASETOKEN caused by a novel combination of MYGENETOKEN G320V/R176C mutations in a 5-year old girl.
24584909	1	1	ENSP00000337014	DOID:2352	Two middle-age-onset MYDISEASETOKEN patients with heterozygous mutations in the MYGENETOKEN gene in a Chinese family.
22297252	1	1	ENSP00000222304	DOID:2352	Identification of a novel mutation in the MYGENETOKEN gene that causes non-detectable MYGENETOKEN molecules in a Japanese male patient with juvenile MYDISEASETOKEN.
16793930	2	4	ENSP00000398698	DOID:2352	Of 86 patients with hereditary MYDISEASETOKEN, 16 (19%) were heterozygous carriers and 1 (1%) was a homozygous carrier of the MYGENETOKEN promoter -308A allele.
14982867	2	8	ENSP00000337014	DOID:2352	These studies confirm that mutations in MYGENETOKEN cause juvenile MYDISEASETOKEN.
24295741	2	3	ENSP00000222304	DOID:2352	In humans, a deficiency or resistance to the iron regulatory hormone, MYGENETOKEN has been implicated in the development of hereditary MYDISEASETOKEN.
28276324	1	1	ENSP00000223051	DOID:2352	MYGENETOKEN-related MYDISEASETOKEN in the Netherlands: a cause of arthralgia in young adulthood.
15986403	2	2	ENSP00000261024	DOID:2352	Mutations in the gene encoding MYGENETOKEN, a cellular iron exporter, are responsible for this MYDISEASETOKEN, inherited as an autosomal dominant trait.
15315789	1	1	ENSP00000337014	DOID:2352	Juvenile MYDISEASETOKEN MYGENETOKEN-related revealed by cardiogenic shock.
21864651	1	1	ENSP00000223051	DOID:2352	Hereditary MYDISEASETOKEN and MYGENETOKEN.
7918084	2	7	ENSP00000366005	DOID:2352	These results refine the HLA-A3 association with MYDISEASETOKEN, suggest that the MYDISEASETOKEN gene is located on the telomeric side of MYGENETOKEN and define a possible haplotype in which the first mutation may have occurred.
22297252	2	2	ENSP00000222304	DOID:2352	In this study, we identified a novel mutation in the MYGENETOKEN gene of a 58-year-old Japanese male patient with MYDISEASETOKEN.
17562347	1	1	ENSP00000223051	DOID:2352	A novel mutation of MYGENETOKEN in a Taiwanese woman with type 3 MYDISEASETOKEN.
17593421	2	4	ENSP00000337014	DOID:2352	MYGENETOKEN (MYGENETOKEN; also called repulsive guidance molecule c, MYGENETOKEN) is the third member of this family, and mutations in this gene result in a form of juvenile MYDISEASETOKEN (type 2A).
24658816	2	1	ENSP00000223051	DOID:2352	MYGENETOKEN (MYGENETOKEN) is a transmembrane glycoprotein expressed in the liver and in the erythroid compartment, mutated in a form of hereditary MYDISEASETOKEN.
21209031	2	1	ENSP00000222304	DOID:2352	MYGENETOKEN inhibits the intestinal absorption of iron and its deficiency causes juvenile MYDISEASETOKEN.
20951701	2	8	ENSP00000250971	DOID:2352	Dolphins with MYDISEASETOKEN had higher post-prandial plasma MYGENETOKEN levels compared to controls.
9556659	2	1	ENSP00000366005	DOID:2352	An ongoing family study of idiopathic MYDISEASETOKEN in Brittany, France, allowed us to investigate the segregation of this trait and its linkage and association to the MYGENETOKEN locus in 147 pedigrees, comprising 1,408 individuals with over 900 characterized for relevant biological parameters and typed for HLA.
15599216	2	3	ENSP00000222304	DOID:2352	Inappropriately low MYGENETOKEN is important to the pathophysiology of hereditary MYDISEASETOKEN.
22535765	2	6	ENSP00000222304	DOID:2352	E2 reduced MYGENETOKEN mRNA in wild-type mice as well as in MYDISEASETOKEN Fe gene knockout mice.
17633910	2	3	ENSP00000333994	DOID:2352	We describe a case of cardiac MYDISEASETOKEN complicated with fatal massive multiorgan embolism due to a large left ventricular thrombus in a patient with MYGENETOKEN.
18925311	2	13	ENSP00000222304	DOID:2352	MYGENETOKEN insufficiency as a primary cause of genetic MYDISEASETOKEN seems unlikely based on the clinical profile of the present patient and the MYGENETOKEN measurements.
22990014	1	1	ENSP00000222304	DOID:2352	Minihepcidins prevent iron overload in a MYGENETOKEN-deficient mouse model of severe MYDISEASETOKEN.
26805813	2	3	ENSP00000222304	DOID:2352	The advance in understanding the main players and mechanisms involved in iron regulation significantly improved since the discovery of genes responsible for MYDISEASETOKEN, the IRE/IRPs machinery, and the MYGENETOKEN-ferroportin axis.
15749661	2	14	ENSP00000223051	DOID:2352	Thus, MYGENETOKEN plays a role in the pathogenesis of MYDISEASETOKEN in Japan.
12663437	2	4	ENSP00000222304	DOID:2352	The key role of MYGENETOKEN is confirmed by the presence of nonsense mutations in the MYGENETOKEN gene, homozygous in the affected members, in 2 families with severe juvenile MYDISEASETOKEN.
21411349	1	11	ENSP00000337014	DOID:2352	Molecular and clinical diagnosis of juvenile MYDISEASETOKEN (homozygous form for the MYGENETOKEN p.G320V) was described for the first time in Brazil.
12469120	2	2	ENSP00000222304	DOID:2352	Here we report the identification of two mutations (93delG and 166C--&gt;T) in MYGENETOKEN on 19q13 in two families with a new type of juvenile MYDISEASETOKEN.
15084147	2	7	ENSP00000223051	DOID:2352	The implications of this observation for the understanding of the phenotypic features of MYDISEASETOKEN due to mutation of the MYGENETOKEN gene are discussed.
12382200	2	11	ENSP00000261024	DOID:2352	Plasma iron, together with dominant inheritance, discriminates iron overload due to ferroportin mutations (MYGENETOKEN) from MYDISEASETOKEN type 1.
15749651	1	1	ENSP00000223051	DOID:2352	Two novel mutations, L490R and V561X, in MYGENETOKEN in Japanese patients with MYDISEASETOKEN.
9659170	2	9	ENSP00000219070	DOID:2352	Serum MYGENETOKEN concentrations correlated with increasing degree of fibrosis in patients with MYDISEASETOKEN (r = 0.38, p = 0.01).
11313241	2	2	ENSP00000223051	DOID:2352	Recently, a new type of MYDISEASETOKEN (MYGENETOKEN) has been characterized in 2 unrelated Italian families with a disorder linked to 7q.
15967692	1	1	ENSP00000337014	DOID:2352	Juvenile MYDISEASETOKEN due to G320V/Q116X compound heterozygosity of MYGENETOKEN in an Irish patient.
18925311	2	2	ENSP00000222304	DOID:2352	It has been speculated that MYGENETOKEN insufficiency or dysregulation may be the primary defect in genetic MYDISEASETOKEN.
15461631	2	1	ENSP00000337014	DOID:2352	Mutations in the chromosome 1q-linked gene MYGENETOKEN (MYGENETOKEN) have recently been found to be a cause of juvenile MYDISEASETOKEN.
16538487	2	2	ENSP00000250971	DOID:2352	We therefore measured glucose tolerance, MYGENETOKEN secretory capacity and insulin sensitivity in adults with MYDISEASETOKEN.
1349563	1	1	ENSP00000366005	DOID:2352	Anonymous markers located on chromosome 6 in the MYGENETOKEN class I region: allelic distribution in genetic MYDISEASETOKEN.
18160816	1	1	ENSP00000261024	DOID:2352	MYGENETOKEN c.1402G--&gt;a results in aberrant splicing, ferroportin truncation after glycine 330, and an autosomal dominant MYDISEASETOKEN phenotype.
15024747	2	3	ENSP00000222304	DOID:2352	We have identified the c.208T&gt;C (p.C70R) mutation in the MYGENETOKEN gene in a patient affected by a severe form of hereditary MYDISEASETOKEN.
12865285	1	1	ENSP00000261024	DOID:2352	A novel mutation in MYGENETOKEN is associated with MYDISEASETOKEN in a Solomon Islands patient.
17949489	2	1	ENSP00000222304	DOID:2352	Hereditary MYDISEASETOKEN (HH) encompasses genetic disorders of iron overload characterized by deficient expression or function of the iron-regulatory hormone MYGENETOKEN.
28694024	2	8	ENSP00000222304	DOID:2352	Non-transfusional secondary MYDISEASETOKEN is due to MYGENETOKEN repression by cytokines, in particular the erythroferone factor that is produced directly by the erythroid precursors.
19937651	2	1	ENSP00000261024	DOID:2352	Mutations in the MYGENETOKEN gene, which encodes ferroportin, are associated with autosomal dominant MYDISEASETOKEN.
15521925	2	2	ENSP00000223051	DOID:2352	Homozygous mutations of MYGENETOKEN cause MYDISEASETOKEN, suggesting that MYGENETOKEN alpha may not be a simple iron transporter, but a regulator of iron by identifying iron-Tf.
15737883	2	8	ENSP00000222304	DOID:2352	At the opposite extreme, early studies indicate that MYGENETOKEN deficiency--due to the dysregulation of its synthesis or mutations in the MYGENETOKEN gene itself--is the immediate cause of most forms of MYDISEASETOKEN.
15319276	2	1	ENSP00000223051	DOID:2352	MYGENETOKEN (MYGENETOKEN) plays a critical role in iron homeostasis because patients carrying disabling mutations in the MYGENETOKEN gene suffer from MYDISEASETOKEN.
20231891	2	6	ENSP00000223051	DOID:2352	MYGENETOKEN null mice are a model of type 3 hereditary MYDISEASETOKEN and develop significant iron overload providing increased iron stores at the onset of infection.
27445804	2	2	ENSP00000222304	DOID:2352	MYGENETOKEN insufficiency causes hyperabsorption of dietary iron, hyperferremia and tissue iron overload, which are hallmarks of hereditary MYDISEASETOKEN.
9088667	2	1	ENSP00000250971	DOID:2352	To determine MYGENETOKEN action and MYGENETOKEN secretory function in patients with MYDISEASETOKEN, and to find evidence for or against hypothesized pathogenetic mechanisms for the abnormal glucose metabolism associated with MYDISEASETOKEN.
19907151	2	5	ENSP00000261024	DOID:2352	The second subgroup of MYDISEASETOKEN is caused by autosomal dominant mutations in the MYGENETOKEN gene encoding the iron exporter ferroportin with distinctive features.
17106152	2	4	ENSP00000337014	DOID:2352	Three patients with mutations in the MYGENETOKEN gene, MYGENETOKEN, showed also middle-age-onset MYDISEASETOKEN.
12704388	1	1	ENSP00000222304	DOID:2352	Constitutive MYGENETOKEN expression prevents iron overload in a mouse model of MYDISEASETOKEN.
12809944	2	9	ENSP00000223051	DOID:2352	Further study was undertaken to investigate whether the large deletion of the MYGENETOKEN gene is the mutation responsible for some of the Japanese MYDISEASETOKEN cases.
18762941	2	8	ENSP00000222304	DOID:2352	Concerning MYGENETOKEN, the deleterious mutation 5'UTR -25G--&gt;A was found once, associated with Juvenile MYDISEASETOKEN.
12637325	2	5	ENSP00000222304	DOID:2352	MYGENETOKEN expression correlated significantly with serum ferritin levels in controls, whereas no significant up-regulation was observed in patients with MYDISEASETOKEN despite iron-overload conditions and high serum ferritin levels.
9149941	2	1	ENSP00000366005	DOID:2352	In the process of positionally cloning a candidate gene responsible for hereditary MYDISEASETOKEN (HH), we constructed a 1.1-Mb transcript map of the region of human chromosome 6p that lies 4.5 Mb telomeric to MYGENETOKEN.
15461631	2	6	ENSP00000337014	DOID:2352	One patient with severe iron overload was found to be a compound heterozygote for MYGENETOKEN mutations, one of which had previously been identified in patients with juvenile MYDISEASETOKEN (G320V) and the other was novel (C321W).
14704284	2	6	ENSP00000222304	DOID:2352	MYGENETOKEN expression is also affected by hypoxia and inflammation and is decreased in MYDISEASETOKEN patients.
17124036	2	8	ENSP00000222304	DOID:2352	This implies that, with the exception of very rare mutations that affect the MYGENETOKEN gene itself or modify ferroportin to make it less responsive to MYGENETOKEN, MYDISEASETOKEN genes encode molecules that regulate MYGENETOKEN synthesis.
15194541	2	2	ENSP00000337014	DOID:2352	We evaluated the frequency of the most common mutation (G320V) of the MYGENETOKEN gene in the Greek population, since 50% of cases of hereditary MYDISEASETOKEN in Greece carry mutations of the MYGENETOKEN gene.
22408404	2	7	ENSP00000337014	DOID:2352	The evaluation of the MYGENETOKEN p.Gly320Val mutation must be the molecular test of choice in suspected patients with juvenile MYDISEASETOKEN with less than 30 years and cardiac or endocrine manifestations.
16099526	1	1	ENSP00000337014	DOID:2352	Three patients with middle-age-onset MYDISEASETOKEN caused by novel mutations in the MYGENETOKEN gene.
15308612	1	1	ENSP00000250971	DOID:2352	Oxidative stress, beta-cell apoptosis, and decreased MYGENETOKEN secretory capacity in mouse models of MYDISEASETOKEN.
11358390	2	17	ENSP00000223051	DOID:2352	Concurrently, none of the 18 hereditary MYDISEASETOKEN patients who had their MYGENETOKEN gene sequenced had any deleterious mutation.
294823	2	12	ENSP00000369351	DOID:2352	MYDISEASETOKEN in MYGENETOKEN occurs frequently and shortens the median survival.
15345587	2	3	ENSP00000223051	DOID:2352	We recently reported that homozygous MYGENETOKEN(Y245X) mutant mice, which correspond to the MYGENETOKEN(Y250X) mutation in humans, showed a phenotype similar to hereditary MYDISEASETOKEN.
27686443	1	1	ENSP00000261024	DOID:2352	[A novel mutation in MYGENETOKEN gene in hereditary MYDISEASETOKEN in China].
14982873	1	1	ENSP00000337014	DOID:2352	Spectrum of MYGENETOKEN gene mutations in 1q-linked juvenile MYDISEASETOKEN.
7078263	2	1	ENSP00000348564	DOID:2352	A 12-year-old girl with MYGENETOKEN, was diagnosed as having MYDISEASETOKEN.
12777185	2	5	ENSP00000308541	DOID:2352	A retrospective study using human genomic DNA samples of known genotype was performed for four different clinically relevant mutations: Factor V Leiden, Factor II MYGENETOKEN, and two MYDISEASETOKEN mutations, C282Y and H63D.
12606179	2	12	ENSP00000261024	DOID:2352	Furthermore, the increase in hepatic MYGENETOKEN expression in MYDISEASETOKEN suggests that MYGENETOKEN could function to facilitate the removal of excess iron from the liver.
16075054	2	1	ENSP00000337014	DOID:2352	Recently, mutations causing juvenile MYDISEASETOKEN have been identified in a novel gene, MYGENETOKEN (MYGENETOKEN), located on chromosome 1.
19549277	1	1	ENSP00000223051	DOID:2352	Natural history of MYGENETOKEN-related hereditary MYDISEASETOKEN in a 47-yr-old Italian patient.
16339398	2	4	ENSP00000222304	DOID:2352	We previously demonstrated that, when expressed early in fetal development, constitutive transgenic MYGENETOKEN expression prevented iron accumulation in an Hfe-/- mouse model of MYDISEASETOKEN.
12547237	1	1	ENSP00000223051	DOID:2352	MYDISEASETOKEN due to mutations in MYGENETOKEN.
22981443	1	1	ENSP00000223051	DOID:2352	Type 3 hereditary MYDISEASETOKEN in a patient from sub-Saharan Africa: is there a link between African iron overload and MYGENETOKEN dysfunction?
7666396	1	1	ENSP00000399168	DOID:2352	Allelic associations and homozygosity at loci from MYGENETOKEN to D6S299 in genetic MYDISEASETOKEN.
11231441	2	1	ENSP00000333994	DOID:2352	Cardiac MYDISEASETOKEN remains the most frequent cause of death in MYGENETOKEN.
8903392	2	1	ENSP00000348068	DOID:2352	Genetic MYDISEASETOKEN and MYGENETOKEN (AAT) deficiency are frequent in white populations.
12138110	1	1	ENSP00000222304	DOID:2352	The solution structure of human MYGENETOKEN, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary MYDISEASETOKEN.
22306005	2	11	ENSP00000222304	DOID:2352	MYGENETOKEN deficiency causes iron overload in hereditary MYDISEASETOKEN and ineffective erythropoiesis.
26408288	1	1	ENSP00000223051	DOID:2352	MYGENETOKEN mutations in patients with juvenile MYDISEASETOKEN phenotype.
1618466	2	5	ENSP00000348068	DOID:2352	We studied 15 patients with genetic MYDISEASETOKEN. MYGENETOKEN quantitation and phenotyping were performed in each case using standard methods.
16793930	2	3	ENSP00000398698	DOID:2352	In patients with homozygous C282Y MYDISEASETOKEN, we investigated the influence of MYGENETOKEN -308G&gt;A allelic variant on total body iron overload, determined in all patients by measuring iron removed during depletion therapy, and hepatic iron index and need for phlebotomy to prevent iron reaccumulation, measured in patient subgroups.
2843458	2	1	ENSP00000366005	DOID:2352	The gene for idiopathic MYDISEASETOKEN is located on the short arm of chromosome 6 within 1 cM of the MYGENETOKEN locus.
26164493	1	1	ENSP00000222304	DOID:2352	Genetics, Genetic Testing, and Management of MYDISEASETOKEN: 15 Years Since MYGENETOKEN.
16075059	2	4	ENSP00000222304	DOID:2352	Juvenile MYDISEASETOKEN patients have decreased urinary levels of MYGENETOKEN, a peptide hormone that binds to the cellular iron exporter ferroportin, causing its internalization and degradation.
18160816	2	10	ENSP00000261024	DOID:2352	We conclude that this patient represents a unique example of MYDISEASETOKEN due to a single base-pair mutation of MYGENETOKEN that results in aberrant splicing and truncation of ferroportin.
21173098	2	1	ENSP00000222304	DOID:2352	Inadequate MYGENETOKEN production leads to iron overload in nearly all types of MYDISEASETOKEN.
24295741	2	6	ENSP00000222304	DOID:2352	Differences in the sequence of the portion of the MYGENETOKEN gene that encodes the mature peptide that might account for the increased susceptibility of the Egyptian fruit bat to MYDISEASETOKEN were not identified.
16793930	2	9	ENSP00000398698	DOID:2352	MYGENETOKEN -308G&gt;A allelic variant modulates iron accumulation in patients with hereditary (homozygous C282Y) MYDISEASETOKEN, but the effect of the MYGENETOKEN -308A allele on clinical manifestations of MYDISEASETOKEN was less accentuated than expected from the increased iron load associated with this allele.
15317665	2	2	ENSP00000223051	DOID:2352	Mutations in MYGENETOKEN result in MYDISEASETOKEN, indicating that this receptor has a unique role in iron metabolism.
26077449	2	3	ENSP00000337014	DOID:2352	Using a genetic MYDISEASETOKEN (MYGENETOKEN knockout mice) and non-genetic (secondary iron-overload) murine models of hepatic iron-overload, we elucidated the mechanism of hepatic iron injury and the therapeutic effects of resveratrol.
15749661	2	13	ENSP00000223051	DOID:2352	Taken together with the previous report, 5 of our 12 patients with MYDISEASETOKEN manifesting in middle age had mutations in the MYGENETOKEN gene.
26669208	2	2	ENSP00000222304	DOID:2352	Dysregulation of MYGENETOKEN leads to altered iron homeostasis and development of pathological disorders including MYDISEASETOKEN, and iron loading and iron restrictive anemias.
20533066	1	1	ENSP00000222304	DOID:2352	Measurement of serum MYGENETOKEN-25 levels as a potential test for diagnosing MYDISEASETOKEN and related disorders.
7615285	1	1	ENSP00000348068	DOID:2352	Increased PiZ gene frequency for MYGENETOKEN in patients with genetic MYDISEASETOKEN.
17551401	1	1	ENSP00000333994	DOID:2352	Magnetic resonance imaging (MRI) findings of joints in young MYGENETOKEN patients: fluid surrounding the scaphoid bone: a novel finding, as the possible effect of secondary MYDISEASETOKEN.
15254010	1	1	ENSP00000337014	DOID:2352	The recently identified type 2A juvenile MYDISEASETOKEN gene (MYGENETOKEN), a second candidate modifier of the C282Y homozygous phenotype.
16075059	2	2	ENSP00000337014	DOID:2352	Mutations in MYGENETOKEN (MYGENETOKEN) cause severe, early-onset juvenile MYDISEASETOKEN.
26027705	2	3	ENSP00000337014	DOID:2352	MYGENETOKEN (HVJ) is a membrane-bound and soluble protein in mammals that is responsible for the iron overload condition known as juvenile MYDISEASETOKEN.
21136275	2	10	ENSP00000222304	DOID:2352	The assay distinguished low MYGENETOKEN level in HCV and homozygous MYDISEASETOKEN patients from normal-range controls and compound heterozygous MYDISEASETOKEN patients.
14224103	1	1	ENSP00000369351	DOID:2352	[MYDISEASETOKEN CAUSED BY SIDEROBLASTIC MYGENETOKEN OF THE BJOERKMAN VARIETY].
23582421	1	1	ENSP00000223051	DOID:2352	A novel rat model of hereditary MYDISEASETOKEN due to a mutation in MYGENETOKEN.
21841161	2	3	ENSP00000222304	DOID:2352	A relative deficiency of MYGENETOKEN underlies the pathophysiology of many of the genetically distinct iron overload disorders, collectively termed hereditary MYDISEASETOKEN.
15897636	2	5	ENSP00000261024	DOID:2352	It was suggested that the mutation in the MYGENETOKEN may be related to MYDISEASETOKEN of this patient.
21675259	2	7	ENSP00000308541	DOID:2352	By one-factor analysis, VTEC was associated with carriage of three heterozygous genotypes: V Leiden factor (p &lt; 0.001), MYGENETOKEN (p = 0.052) and MYDISEASETOKEN (p = 0.048).
15198949	2	4	ENSP00000222304	DOID:2352	We report the detection of a new mutation in the MYGENETOKEN gene leading to juvenile MYDISEASETOKEN in 2 members of a Portuguese family.
26608187	2	5	ENSP00000223051	DOID:2352	Studies from our laboratory have shown that mice with a hepatocyte-specific deletion of MYGENETOKEN recapitulate the MYDISEASETOKEN phenotype of the global MYGENETOKEN knockout mice, suggesting that the hepatic expression of MYGENETOKEN is important in systemic iron homeostasis.
7106343	2	3	ENSP00000250971	DOID:2352	Among the twenty-eight subjects with MYDISEASETOKEN, thirty-two non-diabetics, twenty-six insulin-dependent diabetics, and twenty-four non-MYGENETOKEN-treated diabetics, we observed that the more frequently venesection therapy was performed, the lower the levels of haemoglobin HbAIc, HbAIa+b tended to be.
18951868	2	9	ENSP00000222304	DOID:2352	Urinary MYGENETOKEN levels of 3 to 9 nmol/mmol creatinine(-1) were found in healthy controls, with reduced levels in MYDISEASETOKEN (P&lt;0.00006) and elevated levels in inflammation (P&lt;0.00035).
15521925	2	7	ENSP00000223051	DOID:2352	Furthermore, we demonstrated that mutated MYGENETOKEN alpha (Y250X), which has been reported in patients with hereditary MYDISEASETOKEN, also lost its ability to interact with both human and bovine Tf.
11518736	1	1	ENSP00000261024	DOID:2352	Autosomal-dominant MYDISEASETOKEN is associated with a mutation in the ferroportin (MYGENETOKEN) gene.
15003819	2	10	ENSP00000222304	DOID:2352	They suggest that sex and genetic background, which are regulators of MYGENETOKEN expression, could play a role in the phenotypic expression of genetic MYDISEASETOKEN.
1349563	2	6	ENSP00000366005	DOID:2352	The results suggest two possible locations for the MYDISEASETOKEN gene: less than 100 kb centromeric to the MYGENETOKEN locus, or on the telomeric side.
19287179	2	1	ENSP00000337014	DOID:2352	MYGENETOKEN (MYGENETOKEN) is a membrane protein that is responsible for the iron overload condition known as juvenile MYDISEASETOKEN.
17488680	2	4	ENSP00000222304	DOID:2352	MYGENETOKEN deficiency is the cause of iron overload in most forms of hereditary MYDISEASETOKEN.
15461631	1	1	ENSP00000337014	DOID:2352	MYGENETOKEN (MYGENETOKEN) mutations in persons of European, African-American and Asian ancestry with adult onset MYDISEASETOKEN.
15956209	2	1	ENSP00000261024	DOID:2352	Mutations in the iron exporter ferroportin (Fpn) (MYGENETOKEN, MYGENETOKEN, and MYGENETOKEN) result in MYDISEASETOKEN type IV, a disorder with a dominant genetic pattern of inheritance and heterogeneous clinical presentation.
26142326	2	1	ENSP00000222304	DOID:2352	Iron overload coupled with low MYGENETOKEN levels are characteristics of hereditary MYDISEASETOKEN.
17551401	2	3	ENSP00000333994	DOID:2352	The aim of this study is to determine the possible effects of secondary MYDISEASETOKEN in joints of MYGENETOKEN patients, and to evaluate the sensitivity of magnetic resonance imaging (MRI) compared with plain x-ray, in the early diagnosis of MYDISEASETOKEN of the joints.
16166168	2	3	ENSP00000308541	DOID:2352	We compared WB-RTD PCR with the method for extracted DNA-RTD PCR for the detection of mutations in the MYGENETOKEN (n = 94), factor V Leiden (n = 49), and MYDISEASETOKEN (n = 22) genes.
12382199	2	5	ENSP00000309845	DOID:2352	The type 2 MYDISEASETOKEN locus maps to chromosome MYGENETOKEN, but the gene has not yet been isolated.
17768121	2	1	ENSP00000337014	DOID:2352	In the present study, we correlate homozygosity for the very recently identified MYGENETOKEN p.R176C substitution with a juvenile MYDISEASETOKEN phenotype.
3460331	2	8	ENSP00000399168	DOID:2352	This is the first known example of recombination in an individual with HLA-linked MYDISEASETOKEN in whom the MYDISEASETOKEN allele appeared to segregate with the MYGENETOKEN antigen instead of the -A antigen.
7336414	2	2	ENSP00000366005	DOID:2352	The previously known strong association with A3 was confirmed (RR = 10.6, P less 10(-9)) and our results indicate clearly that a gene implicated in idiopathic MYDISEASETOKEN (IH) determinism is located in the MYGENETOKEN region.
18245657	1	1	ENSP00000223051	DOID:2352	New MYGENETOKEN mutations in young Italian patients with MYDISEASETOKEN.
8304341	2	2	ENSP00000366005	DOID:2352	In an effort to identify candidate genes for MYDISEASETOKEN, this technique was applied to a 320-kb YAC containing the MYGENETOKEN gene.
17997113	1	1	ENSP00000261024	DOID:2352	Analysis of MYGENETOKEN gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary MYDISEASETOKEN type IV.
18045552	2	10	ENSP00000320866	DOID:2352	In C282Y(+/+) patients MYGENETOKEN levels correlated with the expression of the UPR marker BiP and showed a negative association with the number of hereditary MYDISEASETOKEN clinical manifestations.
28930842	2	11	ENSP00000261024	DOID:2352	The present study is the first report to identify a classical splicing mutation in the MYGENETOKEN gene in type 4B MYDISEASETOKEN, and provide further evidence of the prevalence of type 4 hereditary MYDISEASETOKEN in Asian countries.
11431687	1	1	ENSP00000261024	DOID:2352	A mutation in MYGENETOKEN is associated with autosomal dominant MYDISEASETOKEN.
16923517	1	1	ENSP00000223051	DOID:2352	Homozygous p.M172K mutation of the MYGENETOKEN gene in an Italian family with type 3 hereditary MYDISEASETOKEN and early onset iron overload.
24065958	2	2	ENSP00000250971	DOID:2352	Similar to humans with insulin resistance, managed bottlenose dolphins (Tursiops truncatus) diagnosed with MYDISEASETOKEN (iron overload) have higher levels of 2 h post-prandial plasma MYGENETOKEN than healthy controls.
8138245	1	1	ENSP00000366005	DOID:2352	Where does the gene for MYDISEASETOKEN lie in relation to MYGENETOKEN?
5485552	1	1	ENSP00000250971	DOID:2352	[Determination of plasma MYGENETOKEN in primary MYDISEASETOKEN].
17264300	1	1	ENSP00000337014	DOID:2352	Defective targeting of MYGENETOKEN to plasma membrane is a common pathogenetic mechanism in juvenile MYDISEASETOKEN.
15316097	2	10	ENSP00000255030	DOID:2352	Elevated serum ferritin levels could not be explained by an acute phase response as determined by MYGENETOKEN, or MYDISEASETOKEN (DNA analysis).
11551099	2	3	ENSP00000223051	DOID:2352	Recently, a mutation in the gene encoding MYGENETOKEN (exon 6, nucleotide 750 C --&gt; G; Y250X) was detected by a PCR-restriction fragment length polymorphism (RFLP) method in Sicilians with MYDISEASETOKEN.
7078263	1	1	ENSP00000348564	DOID:2352	Use of subcutaneous deferoxamine in a child with MYDISEASETOKEN associated with MYGENETOKEN.
16604073	2	5	ENSP00000337014	DOID:2352	Here, we report that MYGENETOKEN is a BMP coreceptor and that MYGENETOKEN mutants associated with MYDISEASETOKEN have impaired BMP signaling ability.
25666510	2	1	ENSP00000337014	DOID:2352	The gene encoding human MYGENETOKEN (MYGENETOKEN) is one of the genes that, when mutated, can cause juvenile MYDISEASETOKEN, an early-onset inherited disorder associated with iron overload.
17241880	2	2	ENSP00000223051	DOID:2352	Mutations of MYGENETOKEN in humans cause type 3 hereditary MYDISEASETOKEN.
15935710	2	4	ENSP00000261024	DOID:2352	Recently, MYGENETOKEN mutations leading to MYDISEASETOKEN (MYGENETOKEN) have been identified.
12606179	2	8	ENSP00000261024	DOID:2352	Hepatic MYGENETOKEN expression was greatly upregulated in patients with MYDISEASETOKEN (1.8-fold, 95% CI 1.5-2.2; p=0.002).
28930842	1	1	ENSP00000261024	DOID:2352	Type 4B hereditary MYDISEASETOKEN associated with a novel mutation in the MYGENETOKEN gene: A case report and a review of the literature.
16258219	2	5	ENSP00000261024	DOID:2352	These affected subjects were heterozygous for 1467A&gt;C (R489S) in MYGENETOKEN, and without other mutations of the MYDISEASETOKEN genes.
11351203	1	1	ENSP00000333994	DOID:2352	Transfusional MYDISEASETOKEN of the choroid plexus in MYGENETOKEN.
11551099	1	1	ENSP00000223051	DOID:2352	A rapid PCR-SSP assay for the MYDISEASETOKEN-associated Tyr250Stop mutation in the MYGENETOKEN gene.
17019598	1	1	ENSP00000250971	DOID:2352	Increased MYGENETOKEN secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary MYDISEASETOKEN.
12091366	1	1	ENSP00000261024	DOID:2352	Novel mutation in MYGENETOKEN is associated with autosomal dominant MYDISEASETOKEN.
7874124	2	5	ENSP00000366005	DOID:2352	The MYDISEASETOKEN critical region extending from proximal of MYGENETOKEN to distal of D6S105 is therefore large.
9303489	1	1	ENSP00000221930	DOID:2352	Excess iron induces hepatic oxidative stress and MYGENETOKEN in genetic MYDISEASETOKEN.
15749661	1	1	ENSP00000223051	DOID:2352	Two novel mutations, L490R and V561X, of the MYGENETOKEN gene in Japanese patients with MYDISEASETOKEN.
16424663	1	1	ENSP00000337014	DOID:2352	A juvenile MYDISEASETOKEN patient homozygous for a novel deletion of cDNA nucleotide 81 of MYGENETOKEN.
26266058	2	2	ENSP00000333994	DOID:2352	MYGENETOKEN is one of the causes of secondary MYDISEASETOKEN due to regular transfusional treatment for maintaining adequate levels of hemoglobin.
20234129	1	1	ENSP00000337014	DOID:2352	MYDISEASETOKEN and MYGENETOKEN G320V homozygosity in a Hungarian woman.
16257244	1	1	ENSP00000261024	DOID:2352	Autosomal dominant hereditary MYDISEASETOKEN associated with two novel MYGENETOKEN mutations in Spain.
24584909	2	2	ENSP00000337014	DOID:2352	Here, we report a heterozygous genotype at two mutation sites in MYGENETOKEN (MYGENETOKEN) present in two brothers with middle-age-onset MYDISEASETOKEN in a Chinese family.
15703643	2	7	ENSP00000261024	DOID:2352	A mutation in MYGENETOKEN produced a form of MYDISEASETOKEN with excessive iron in hepatocytes and also in Kupffer cells and macrophages.
7918084	2	4	ENSP00000366005	DOID:2352	Allele 8 of the more telomeric locus D6S105 was also strongly associated with MYDISEASETOKEN (RR = 13.0; Chi2 = 21.1) but alleles at this locus were not in strong linkage disequilibrium with MYGENETOKEN alleles in the control subjects.
6167540	2	1	ENSP00000366005	DOID:2352	The purpose of this paper is to report a pedigree with hereditary MYDISEASETOKEN in which a recombination between the MYGENETOKEN and B loci occurred.
